Tagged with S

argenx Carl-Michael Simon, Country Manager for Mid-Size Markets at argenx, discusses how the company has grown from its Dutch and Belgian origins into a global biotech delivering precision medicines for autoimmune diseases. From the landmark approval of VYVGART to new formulations, market access strategies, and the ambitious goal of reaching 50,000…

Switzerland Dr. Dragan Grabulovski, CEO and co-founder of Araris, shared how his journey from co-founding Covagen to advising venture firms shaped his vision for building a platform-driven biotech company. He explained how Araris’s proprietary conjugation technology solves key limitations in ADC development, including enabling multi-payload approaches for greater efficacy. “Our vision…

USA Marwan Fathallah, President and CEO of DIA, outlines how the organisation has evolved into a neutral platform bringing together regulators, industry, and academia to navigate the most pressing issues in healthcare and life sciences. From the transformative potential of AI to the realities of drug pricing, onshoring, and global competition,…

Switzerland Henric Bjarke, CEO of Tenpoint Therapeutics with offices in Basel, Switzerland, highlights the company’s de-risked presbyopia program, strong team, and large global market. With a career spanning landmark launches like latanoprost and anti-VEGF therapies, he describes the enduring pull of ophthalmology. Tenpoint is preparing for the 2026 launch of its…

France Professor Alain Puisieux, President of the Executive Board at Institut Curie, leads the renowned cancer centre through an integrated strategy combining cutting-edge research and patient care. With a scientific background in cancer cell plasticity, he focuses on accelerating translational research, interdisciplinary collaboration, and equitable clinical trial access. Puisieux emphasises the…

France Founded in 2017 as part of France’s national health export strategy, the French Healthcare Association brings together more than 300 members from across the health ecosystem to showcase and support French expertise abroad. In this conversation, CEO Emile Jockey discusses how the association acts as a bridge between the public…

USA Richard Pazdur, MD, Director of the Oncology Centre of Excellence (OCE) at the US Food and Drug Administration (FDA), leads the agency’s efforts to streamline and modernize the regulation of cancer therapies. Since its creation in 2017, the OCE has become a hub for innovation, fostering collaboration across FDA centres,…

China This week’s China biopharma roundup from PharmaBoardroom content partner Selesta covers Novartis’ USD 5.4bn expansion with Argo in cardiovascular siRNA, Hengrui’s USD 1.1bn out-licensing of its cardiac myosin inhibitor, Novatim’s USD 1.15bn ADC deal with Radiance, Convalife’s Hong Kong IPO filing, and Fosun’s TYK2/JAK1 rights buy. On the clinical side,…

Switzerland New Idorsia CEO Srishti Gupta is emphasising “financial discipline” as she looks to turn around the fortunes of one of Europe’s top biotechs.   Challenging Times Gupta, who spent almost two decades at consultancy firm McKinsey, inherits a company that managed to launch three drugs in its first seven years…

China The top 20 Chinese pharma companies ranked by 2023 sales, according to the Citelie Scrip Asia 100. CSPC, Fosun, and Shanghai Pharma top the chart, with a host of other less well-known firms now also generating over a billion dollars in annual sales.   Made with Visme Infographic Maker

Switzerland As Medinova marks 80 years since its founding in Zurich, General Manager Olga Lamua Olivar is charting the path forward for the boutique specialty pharma player. With a career spanning multiple countries and disciplines, she brings the breadth of experience needed to guide Medinova through its next transformation. Her strategy…

Switzerland Amid structural reforms and shifting expectations across the Swiss healthcare system, Marco Caruso’s return to Medtronic marks a renewed focus on patient impact, equitable access, and long-term value. Speaking from the intersection of leadership, policy, and innovation, Caruso offers sharp insights into how one of the world’s largest medtech companies…